chloroquine has been researched along with Antiphospholipid Syndrome in 7 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
Excerpt | Relevance | Reference |
---|---|---|
"Antiphospholipid syndrome is an autoimmune disease that is characterised by tendency to thrombosis, obstetrical and hematological complications." | 1.33 | Nocardiosis in a patient with primary anti-phospholipid syndrome. ( Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Dos Reis Neto, ET | 1 |
Kakehasi, AM | 1 |
de Medeiros Pinheiro, M | 1 |
Ferreira, GA | 1 |
Marques, CDL | 1 |
da Mota, LMH | 1 |
Dos Santos Paiva, E | 1 |
Pileggi, GCS | 1 |
Sato, EI | 1 |
Reis, APMG | 1 |
Xavier, RM | 1 |
Provenza, JR | 1 |
Caldas, CA | 1 |
de Carvalho, JF | 1 |
Katz, SJ | 1 |
Russell, AS | 1 |
Soy, M | 1 |
Oktun, MT | 1 |
Tunçbilek, N | 1 |
Ermantaş, N | 1 |
Okten, O | 1 |
Altinay, G | 1 |
Turgut, B | 1 |
Evereklioglu, C | 1 |
Suarez, IM | 1 |
Diaz, RA | 1 |
Aguayo Canela, D | 1 |
Pujol de la Llave, E | 1 |
Wallace, DJ | 1 |
3 reviews available for chloroquine and Antiphospholipid Syndrome
Article | Year |
---|---|
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
Topics: Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; | 2020 |
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
Topics: Annexin A5; Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Cardiovascular Diseases; | 2011 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Topics: Antimalarials; Antiphospholipid Syndrome; Autoimmune Diseases; Chloroquine; Controlled Clinical Tria | 1996 |
4 other studies available for chloroquine and Antiphospholipid Syndrome
Article | Year |
---|---|
Primary antiphospholipid syndrome with and without Sneddon's syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Chloroquine; Female; Glucocorticoids; Hum | 2011 |
Nocardiosis in a patient with primary anti-phospholipid syndrome.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Age | 2006 |
The treatment schedule and historical naming process of Behçet disease.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Antirheumatic Agents; Behcet Syndrome | 2007 |
Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Chloroquine; Female; Follow-Up Studies; Huma | 1996 |